Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

JAK inhibitors may reduce depression in people with alopecia areata.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Vitamin C derivative reduces hair loss-related protein in cells.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.

Using special RNA to target a mutant gene fixed hair problems in mice.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

A method was found to select hair follicle stem cells, and beta-catenin helps them grow and change.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Peficitinib can turn human fibroblasts into cells that help grow hair.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.